Magnetic Resonance Imaging Quantification of the Liver Iron Burden and Volume Changes Following Treatment With Thalidomide in Patients With Transfusion-Dependent ß-Thalassemia
Clinical trials have indicated that thalidomide could be used to treat thalassemia, but evidence of changes in liver iron burden and liver volume during thalidomide treatment is lacking. This study aimed to evaluate the liver iron burden and volume changes following thalidomide treatment in patients...
Main Authors: | Jinlian Che, Tianying Luo, Lan Huang, Qiyang Lu, Da Yan, Yinying Meng, Jinlan Xie, Weihua Chen, Jiangming Chen, Liling Long |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.810668/full |
Similar Items
-
Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia
by: Yaocheng Chen, et al.
Published: (2020-07-01) -
Investigating the Efficacy and Safety of Thalidomide for Treating Patients With ß-Thalassemia: A Meta-Analysis
by: Yanfei Lu, et al.
Published: (2022-01-01) -
SAFETY AND EFFICACY OF THALIDOMIDE IN TRANSFUSION-DEPENDENT β-THALASSEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: Zahid Ali, et al.
Published: (2022-09-01) -
Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study
by: Xinyu Li, et al.
Published: (2021-08-01) -
Management of ß-thalassemia – Consensus and controversies!
by: Mamta V. Manglani, et al.
Published: (2017-12-01)